Acquisitions and Other Strategic Transactions (Tables)

12 Months Ended

Dec. 31, 2020

Business Acquisition [Line Items]

Business Acquisition, Pro Forma Information

The following table summarizes our consolidated results of operations for the year ended December 31, 2018, as well as unaudited pro forma consolidated results of operations as though the 2018 acquisitions of Cianna Medical and Vascular Insights had occurred on January 1, 2017 (in thousands, except per common share amounts):

	2018
	As Reported		Pro Forma
Net sales	$	882,753	$	928,336
Net income		42,017		20,699
Earnings per common share:
Basic	$	0.80	$	0.40
Diluted	$	0.78	$	0.38

Note: The pro forma results for the years ended December 31, 2020 and 2019 are not included in the table above because the operating results of the Cianna Medical, and Vascular Insights acquisitions were included in our consolidated statements of income (loss) for these periods.

KA Medical

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Assets Acquired
Trade receivables	$	24
Other receivables		13
Inventories		216
Property and equipment		298
Other long-term assets		147
Intangible assets
Developed technology		6,000
Goodwill		8,283
Total assets acquired		14,981
Liabilities Assumed
Trade payables		(31)
Accrued expenses		(507)
Total liabilities assumed		(538)
Total net assets acquired	$	14,443

Business Acquisitions 2019

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

	STD Pharmaceutical		Brightwater
Assets Acquired
Trade receivables	$	277	$	55
Inventories		843		349
Prepaid expenses and other current assets		49		—
Property and equipment		—		409
Other long-term assets		—		30
Intangible assets
Developed technology		10,428		31,960
Customer lists		—		83
Trademarks		—		250
Goodwill		4,975		17,607
Total assets acquired		16,572		50,743
Liabilities Assumed
Trade payables		(53)		(58)
Accrued expenses		(29)		(261)
Other long-term obligations		—		(1,522)
Deferred income tax liabilities		(1,890)		(4,263)
Total liabilities assumed		(1,972)		(6,104)
Total net assets acquired	$	14,600	$	44,639
Amortization Period of Intangible Assets
Developed technology		12 years		13 years
Customer lists (on an accelerated basis)		—		1 year
Trademarks		—		5 years
Weighted Average		12 years		12.9 years

Business Acquisitions 2018

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

	Vascular Insights		Cianna Medical		DirectACCESS		BD
Assets Acquired
Trade receivables	$	—	$	6,151	$	—	$	—
Inventories		1,353		5,803		971		5,804
Prepaid expenses and other current assets		—		315		—		—
Property and equipment		—		1,047		—		748
Other long-term assets		—		14		—		—
Intangibles
Developed technology		32,750		134,510		4,840		74,000
Customer list		840		3,330		120		4,200
Trademarks		1,410		7,080		400		4,900
In-process technology		—		—		—		2,500
Goodwill		21,832		61,379		938		9,728
Total assets acquired		58,185		219,629		7,269		101,880
Liabilities Assumed
Trade payables		—		(1,497)		—		—
Accrued expenses		—		(2,384)		—		—
Other long-term liabilities		—		(1,527)		—		—
Deferred income tax liabilities		—		(25,940)		—		—
Total liabilities assumed		—		(31,348)		—		—
Total net assets acquired	$	58,185	$	188,281	$	7,269	$	101,880
Amortization Period of Intangible Assets
Developed technology		12 years		11 years		10 years		8 years
Customer lists (on an accelerated basis)		8 years		8 years		5 years		7 years
Trademarks		9 years		10 years		10 years		9 years
Weighted Average		11.8 years		10.7 years		9.9 years		8.0 years
Sales for the years ended
December 31, 2020		$5.5 million		$45.3 million		Not Material		$42.6 million
December 31, 2019		$7.5 million		$49.5 million		Not Material		$46.8 million
December 31, 2018		Not Material		$6.3 million		Not Material		$42.1 million